Table 3 |
||
|
Side effects in each treatment group. |
||
|
QT |
OAR |
|
|
|
||
|
Total patients |
35 (64%) * |
20 (44%) * |
|
Dyspepsia |
||
|
+ |
17 |
8 |
|
+++ |
1 |
1 |
|
Taste-sensation alteration |
||
|
+ |
12 |
5 |
|
+++ |
2 |
|
|
Dizziness |
||
|
+ |
13 |
4 |
|
+++ |
1 |
|
|
Diarrhoea |
||
|
+ |
10 |
6 |
|
+++ |
1 |
|
|
Nausea/Vomiting |
||
|
+ |
10 |
5 |
|
+++ |
3 |
1 |
|
Loss of appetite |
||
|
+ |
9 |
6 |
|
+++ |
2 |
|
|
Cephalea |
||
|
+ |
8 |
6 |
|
+++ |
1 |
1 |
|
Odynophagia |
||
|
+ |
4 (2 candidiasis) |
|
|
+++ |
||
|
Asthenia/tiredness |
||
|
+ |
2 |
3 |
|
+++ |
||
|
Total episodes |
85 |
43 |
|
Total episodes +++ |
11 |
3 |
|
|
||
|
* p 0.042 +: : mild/moderate +++: : severe |
||
|
Navarro-Jarabo et al. BMC Gastroenterology 2007 7:31 doi:10.1186/1471-230X-7-31 |
||
